Voxar's latest 3D version 4.2 has been integrated into Agfa's PACS solution, Impax. The integration is the result of a global distribution agreement that Agfa and Voxar signed late last year. The new software allows PET visualization and simultaneous
Voxar's latest 3D version 4.2 has been integrated into Agfa's PACS solution, Impax. The integration is the result of a global distribution agreement that Agfa and Voxar signed late last year. The new software allows PET visualization and simultaneous comparison of PET and CT images, as well as state-of-the-art image enhancement and measurement tools. One-click processes allow 2D, 3D, maximum-intensity projection, and multiplanar reconstruction. Automatic MPR Shape Selection enables selection, measurement, and display of complex heterogeneous structures. Protected health information is stripped from DICOM images using features integral to the application.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.